Ceapro Announces Signing of Growing Forward 2 Agreement
EDMONTON, ALBERTA -- (Marketwired) -- 08/13/13 -- Ceapro Inc. (TSX VENTURE:CZO) is pleased to announce that it has signed an Agri-Processing Automation and Efficiency Grant Agreement with Alberta Agriculture and Rural Development. This program operates pursuant the Growing Forward 2 Agreement.
Under the terms and conditions of the Agreement signed, Ceapro is eligible for a contribution of up to $673,000 by way of grant for certain eligible capital and non-capital expenses that are approved.
"The funding provided by this program will be utilized to support equipment and related costs for our new manufacturing facility currently under construction in Edmonton. We are grateful for the support provided by the Government of Alberta and its commitment to growing the innovative agri-processing sector that Ceapro participates in", said Gilles Gagnon, President and CEO of Ceapro. "We look forward to commercializing several new products to be manufactured in this facility and adding value to the Alberta agriculture industry" he added.
About Ceapro Inc.
Ceapro Inc. is a Canadian growth-stage biotechnology company. Primary business activities relate to the development and commercialization of natural products for personal care and cosmetic industries using proprietary technology and natural, renewable resources. The commercial line of natural active ingredients include beta glucan, avenanthamides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides.
To learn more about Ceapro, visit www.ceapro.com
The TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Chief Financial Officer
Telephone (Edmonton): (780) 917-8376
Source: Ceapro Inc.
Released August 13, 2013